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Abstract
An imbalance between cholinergic and noradrenergic neurotransmis-
sion has been proposed for the etiology of affective disorders. Accord-
ing to this hypothesis, depression would be the result of enhanced
cholinergic and reduced noradrenergic neurotransmission. Repeated
electroconvulsive shock (ECS) is an effective treatment for depres-
sion; moreover, in laboratory animals it induces changes in brain
noradrenergic neurotransmission similar to those obtained by chronic
treatment with antidepressant drugs (down-regulation of beta-adre-
nergic receptors). The aim of the present study was to determine
whether repeated ECS in rats changes acetylcholinesterase (Achase)
activity. Achase controls the level of acetylcholine (Ach) in the
synaptic cleft and its levels seem to be regulated by the interaction
between Ach and its receptor. Thus, a decrease in Achase activity
would suggest decreased cholinergic activity. Adult male Wistar rats
received one ECS (80 mA, 0.2 s, 60 Hz) daily for 7 days. Control rats
were handled in the same way without receiving the shock. Rats were
sacrificed 24 h after the last ECS and membrane-bound and soluble
Achase activity was assayed in homogenates obtained from the pons
and medulla oblongata. A statistically significant decrease in mem-
brane-bound Achase activity (nmol thiocholine formed min-1 mg
protein-1) (control 182.6 ± 14.8, ECS 162.2 ± 14.2, P<0.05) and an
increase in soluble Achase activity in the medulla oblongata (control
133.6 ± 4.2, ECS 145.8 ± 12.3, P<0.05) were observed. No statistical
differences were observed in Achase activity in the pons. Although
repeated ECS induced a decrease in membrane-bound Achase activ-
ity, the lack of changes in the pons (control Achase activity: total 231.0
± 34.5, membrane-bound 298.9 ± 18.5, soluble 203.9 ± 30.9), the
region where the locus coeruleus, the main noradrenergic nucleus, is
located, does not seem to favor the existence of an interaction between
cholinergic and noradrenergic neurotransmission after ECS treatment.
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Electroconvulsive shock (ECS) is a clas-
sical antidepressive treatment (1) and its
therapeutical effect is observed after repeated
sessions. The time span between the onset of
treatment and the improvement in mood
seems to be related to adaptive biochemical
changes that occur in the brain. In laboratory
animals, repeated ECS treatment induces
changes in noradrenergic neurotransmission
which are similar to those produced by
chronic antidepressant drugs, including
down-regulation of beta-adrenergic recep-
tors and reduced synthesis of cyclic adeno-
sine monophosphate (cAMP) induced by
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noradrenergic agonists (for a review, see
Ref. 2).
An imbalance between noradrenergic and
cholinergic neurotransmission has been pro-
posed for the etiology of affective disorders
(for a review, see Ref. 2). According to this
hypothesis, depression may be the result of
an overactive cholinergic neurotransmission
and reduced noradrenergic activity. Antide-
pressant drugs (inhibitors of noradrenaline
uptake and monoamine oxidase activity)
along with ECS seem to improve depression
by increasing noradrenergic neurotransmis-
sion (2). According to the noradrenergic-
cholinergic interaction hypothesis, these
treatments should lead to a decrease in cho-
linergic neurotransmission.
The brainstem is the brain region where
the cell bodies of noradrenergic neurons are
located (3). This brain region also has cell
bodies of cholinergic neurons anatomically
connected to noradrenergic neurons (4) and
they interact mutually (5). The locus coeru-
leus (LC) is the main noradrenergic nucleus
in the brainstem and sends projections to
several brain areas, including the hippocam-
pus and cerebral cortex (3) according to a
spatial distribution within the nucleus (6).
The locus coeruleus receives cholinergic in-
puts from brainstem cholinergic neurons (4)
and acetylcholine (Ach) acting on M2-mus-
carinic receptors increases the firing rate of
LC neurons (7). Acetylcholinesterase
(Achase), the enzyme that inactivates Ach,
is located postsynaptically (8) and has been
reported to be present in the membranes of
LC neurons (9). Large territories of the brain-
stem that receive a dense noradrenergic in-
put are very sparsely innervated by LC neu-
rons (10). Repeated ECS increases tyrosine
hydroxylase activity and its messenger RNA
in LC (11,12). Taken together, these data
indicate that the brainstem is an appropriate
brain region for the study of a possible inter-
action between cholinergic and noradrener-
gic neurotransmission after ECS treatment.
To our knowledge, there is no previous
report on the effects of repeated ECS on
Achase activity in the pons and medulla
oblongata. Appleyard et al. (13) have re-
ported no change in Achase activity in the
whole brainstem of female rats after only
one convulsion induced by ECS. The aim of
the present study was to determine whether
repeated ECS treatment in rats induces a
decrease in Achase activity. Achase is the
enzyme responsible for Ach inactivation and
controls the levels of Ach in the synaptic
cleft (14). Moreover, the level of the enzyme
appears to be controlled by Ach interacting
with its receptor (15). Thus, a change in
Achase activity could be an indication of
altered cholinergic activity.
Adult male Wistar rats (3 months old)
received one ECS treatment daily for 7 days
(80 mA, 0.2 s, 60 Hz) by means of ear-clip
electrodes. All ECS-treated rats presented a
full tonic-clonic convulsion. Control rats were
handled in the same way as the experimental
group, except that no shock was delivered.
Control and experimental rats were decapi-
tated 24 h after the last ECS session and the
brainstem was dissected and divided into its
subregions, pons and medulla oblongata.
Homogenates of these brain regions were
prepared in cold 0.32 M sucrose and centri-
fuged in order to obtain membrane-bound
and soluble Achase (16). Total (900 g super-
natant), membrane-bound (100,000 g sedi-
ment) and soluble (100,000 g supernatant)
Achase activity was assayed photometrically
using acetylthiocholine as the substrate (1
mM final concentration in the assay) as de-
scribed in detail elsewhere (17). The assay
was carried out in the linear range for both
protein concentration and incubation time.
Protein was assayed in the homogenates (18)
and the enzyme specific activity is reported
as nmol thiocholine formed min-1 mg pro-
tein-1.
There was a statistically significant de-
crease in the activity of membrane-bound
Achase in the medulla oblongata (t = 2.26,
d.f. = 8, P<0.05, one-tailed unpaired Student
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t-test) (Table 1), and an increase in the activ-
ity of the soluble enzyme (t = 2.10, d.f. = 8,
P<0.05) (Table 1). The ECS treatment did
not induce any significant alteration in the
activity of either enzyme form in the pons
(P>0.05) (Table 1).
Achase seems to be mainly located post-
synaptically in the brain (8). Most of the
Achase present in mammalian brain is the
globular G4 form which is virtually mem-
brane-bound and predominantly extracellu-
lar (14). This form of the enzyme also pre-
dominates in the brainstem (19). In skeletal
muscle, the amount of Achase G4 isoform is
controlled by an interaction between Ach
and the cholinergic receptor (15). Increased
frequency of Ach-cholinergic receptor inter-
action enhances the production of this
isoform. Thus, the decrease in Achase bound
to membranes in the medulla oblongata might
indicate a reduced Ach-cholinergic receptor
interaction, which may reflect a decrease in
cholinergic activity in this brain region. Since
there is no previous indication of any in-
volvement of the medulla oblongata in the
antidepressant effect of ECS, the change in
Achase activity obtained in this brain region
may not be associated with the antidepres-
sant effect of ECS. The lack of change in
Achase activity observed in the pons, the
brain region where the most important nor-
adrenergic nucleus (LC) is located (3,6),
may also indicate that the change in Achase
activity observed in the medulla oblongata
is not involved in the antidepressant effect
of ECS.
We also measured Achase activity in sev-
eral other brain regions (whole cerebral cor-
tex, frontal cortex, hippocampus, striatum
and thalamus) after repeated ECS (data not
shown). These brain areas are known to
receive cholinergic and noradrenergic in-
puts (3,4,6). The data obtained in these stud-
ies showed no statistically significant differ-
ences in Achase activity after ECS treat-
ment. These results are consistent with pre-
vious data obtained for female rats after 10
ECS (20), with the exception of the striatum
where an increase in Achase activity was
reported. However, we were not able to dem-
onstrate an increase of Achase activity in the
striatum using male rats and 7 ECS sessions
and cannot explain the difference between
our results and those reported in Ref. 20.
Although we demonstrated a decrease in
membrane-bound Achase activity in the
medulla oblongata after repeated ECS treat-
ment, the lack of change in enzyme activity
in the pons and other brain regions assayed
does not favor the hypothesis of a noradre-
nergic-cholinergic interaction.
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Table 1 - Specific activity of Achase in the medulla oblongata and pons of rats after
chronic ECS treatment.
Rats received one ECS daily for 7 days and were sacrificed 24 h after the last ECS.
Achase was assayed using acetylthiocholine as the substrate. Data are reported as
mean ± SD (N = 5 for all measurements). *P<0.05 compared to control (Student t-test).
Brain region Achase activity
(nmol thiocholine formed min-1 mg protein-1)
Total Membrane-bound Soluble
(900 g supernatant) (100,000 g sediment)  (100,000 g supernatant)
Medulla oblongata
Control 152.6 ± 7.9 182.6 ± 14.8 133.6 ± 4.2
ECS 158.4 ± 7.4 162.2 ± 14.2* 145.8 ± 12.3*
Pons
Control 231.0 ± 34.5 298.9 ± 18.5 203.9 ± 30.9
ECS 242.4 ± 39.7 297.9 ± 34.7 204.3 ± 32.6
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